Lunit Completes Acquisition of Volpara Health Read more

Computer Aided Detection / Diagnosis Software for Mammography

  1. MMG_Korea MFDS : [Product Name] Computer Aided Detection / Diagnosis Software for Mammography / [Product License No.] 제허 19-493호 / [Date of Initial Approval] 29 July 2019 / [Validity Period] 8 October 2020 – 31 May 2030 [Issuer ] The Ministry of Food and Drug Safety
  2. MMG_FDA : [510(k) number] K211678 / [Decision Date] : 17 November 2021 [Issuer] FDA
  3. MMG_CE : EC Certificate issued under the European Medical Device Regulation (EU MDR) [First Issue Date] 31 October 2022 / [Expiry Date] 30 October 2027 / [Issuer] BSI


Lunit INSIGHT MMG accurately detects lesions suspicious of breast cancer in a mammogram.

Soft-tissue lesion

Global Partners


Breast Density Assessment

Lunit INSIGHT MMG automatically analyzes and generates quantitative density assessment* during breast screening.

* Not available in the U.S.A

Users can choose two options for breast density: 'Case Level' and 'Side Level'
Case Level : Indicates the average density of both breasts
Side Level : Indicates the density of each breast

Check EUSOBI Guideline

Recently, the European Society of Breast Imaging (EUSOBI) released its new recommendations that patients should be informed of their breast density when screened.

Aid for Breast Cancer Detection

According to a paper published in JAMA Oncology, Lunit INSIGHT MMG showed outstanding performance for breast cancer detection.

Figure. Receiver Operating Characteristic Curves for the
3 Artificial Intelligence Computer-Aided Detection Algorithms
Read Clinical Evidence

Mattie Salim, Erik Wåhlin, Karin Dembrower, et al. External Evaluation of 3 Commercial Artificial Intelligence Algorithms for Independent Assessment of Screening Mammograms.

Diagnostic aid for dense breast

According to a paper published in THE LANCET Digital Health, the accuracy of cancer diagnosis improved by 12% when Lunit INSIGHT MMG assisted in reading dense breast cases.

In addition, it has been reported that the accuracy of fatty breast cancer diagnosis improved by 5% when Lunit INSIGHT MMG assisted in reading mammograms.

Dense breast cancer diagnosis assisted by AI increased by 12%

12 %

Fatty breast cancer diagnosis assisted by AI increased by 5%

5 %
Read Clinical Evidence

Hyo-Eun Kim, Hak Hee Kim, et al. Changes in cancer detection and false-positive recall in mammography using artificial intelligence: a retrospective, multireader study.

Workflow Efficiency

60 %

According to a study published in THE LANCET Digital Health,
it is possible to triage 60% of all cases as normal without missing any breast cancer.
The suggested workflow model, of which the AI score functions as supportive information, reduces radiologists’ reading volume and complements their interpretations.

Diagnosis of exclusion ᅳ 60% of the entire cases were triaged into the exclusion category, which can be interpreted as negative cases in screening tests.

Read Clinical Evidence

Karin Dembrower, Erik Wåhlin, et al. Effect of artificial intelligence-based triaging of breast cancer screening mammograms on cancer detection and radiologist workload: a retrospective simulation study.

The algorithm is updated annually with additional training datasets or new features by the manufacturer to manage the performance.

As this product is a medical device, please read the user manual carefully before use.

Publications featuring

The publications listed below are not subject to the review of medical device advertising and are intended to showcase Lunit’s technology.

No Data

Learn more about Lunit INSIGHT MMG

What do the medical journals say about AI-powered mammography?

Watch the animated video about Lunit INSIGHT MMG featured in peer-reviewed journals


Computer-Aided Detection / Diagnosis Software for Chest X-ray, Class Ⅱ


Making data-driven medicine a reality